Literature DB >> 7757387

[The greater celandine (Chelidonium majus L.)--review of present knowledge].

E Táborská1, H Bochoráková, J Dostál, H Paulová.   

Abstract

The greater celandine (Chelidonium majus L.) is a species of the Papaveraceae family. The principal secondary metabolites of the plant are isoquinoline alkaloids; more than 30 were found here. The richest organ is the root, the total content of alkaloids in it reaching 2-3%. The dominant alkaloids of the root are chelidonine and coptisine. The aerial parts contain about 0.5-1.5% alkaloids. The principal base for the whole period of vegetation is coptisine, the representation of other alkaloids substantially changing during the development of the plant. Of nonalkaloidal secondary metabolites, esters of caffeic acid have recently been demonstrated in the plant drug. In the past, the drug was used to treat tumours. At present, the extract of alkaloids from the plant is the base of the preparation Ukrain showing immunomodulating activity and being employed in the therapy of different types of carcinomata. Chelidonium majus is also a component of some preparations employed in the diseases of the biliary tract and liver. Biological effect of the principal constituents of the drug are different and often quite antagonistic. As their representation varies in the course of vegetation, the efficacy of the summary preparations changes in dependence on the prevailing substance in the preparation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757387

Source DB:  PubMed          Journal:  Ceska Slov Farm        ISSN: 1210-7816


  4 in total

1.  Evaluation of the heterogeneity and specificity of promising antitumoral preparations by means of high-order derivative spectroscopy.

Authors:  YuG Zhukovskii; V S Saakov
Journal:  Dokl Biol Sci       Date:  2002 Sep-Oct

2.  In vivo anthelmintic activity of chelidonine from Chelidonium majus L. against Dactylogyrus intermedius in Carassius auratus.

Authors:  Jia-Yun Yao; Zhi-Ming Zhou; Xiao-yi Pan; Gui-jie Hao; Xi-Lian Li; Yang Xu; Jin-Yu Shen; Hong-shun Ru; Wen-lin Yin
Journal:  Parasitol Res       Date:  2011-05-03       Impact factor: 2.289

3.  Activity of the chelerythrine, a quaternary benzo[c]phenanthridine alkaloid from Chelidonium majus L. on Dactylogyrus intermedius.

Authors:  Xi-Lian Li; Jia-Yun Yao; Zhi-Ming Zhou; Jin-Yu Shen; Hong-Shun Ru; Xiao-Lin Liu
Journal:  Parasitol Res       Date:  2011-03-12       Impact factor: 2.289

Review 4.  Greater Celandine's Ups and Downs-21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today's Pharmacology.

Authors:  Sylwia Zielińska; Anna Jezierska-Domaradzka; Magdalena Wójciak-Kosior; Ireneusz Sowa; Adam Junka; Adam M Matkowski
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.